Mrs
Dr
Miss
Ms
Prof
Printer Friendly
Printed from http://www.researchandmarkets.com/reports/1412738
Cytori Therapeutics, Inc. (XMP) - Product Pipeline Analysis
Description:
Cytori Therapeutics, Inc. (XMP) - Product Pipeline Analysis
Summary
Cytori Therapeutics, Inc. (Cytori) is a medical device company, engaged in the development and commercialization of stem and regenerative cell therapies for the treatment of cardiovascular disease, reconstructive surgery and many other serious, chronic, and life threatening conditions. The company’s primary technology is the patented Celution family of products which processes patients’ adipose-derived stem and regenerative cells (ADRCs) at the point of care. It sells its products directly or through distribution partners in various European countries including Finland, Italy, the Netherlands, Norway, Portugal, Spain, Austria, Belgium, Denmark, Germany, Greece, Sweden, Switzerland, Turkey, and the UK, as well is in select Asian, the Middle Eastern, and eastern European countries. Cytori is headquartered in San Diego, California, the US.
This report is a source for data, analysis and actionable intelligence on the Cytori Therapeutics, Inc. portfolio of pipeline products. The report provides detailed analysis on each pipeline product with information on the indication, the development stage, trial phase, product milestones, pipeline territory, estimated approval date, and estimated launch date.
Each pipeline product is profiled to cover information on product description, function, technology, indication, and application. The report is also supplemented with a detailed company profile and information on clinical trials, wherever applicable.
This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.
Scope
- Detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments.
- Detailed coverage on all the pipeline products, by equipment type, by therapy area, by development stage, and by trial phase.
- Information on product milestones and pipeline territory for each product, the estimated approval date, and estimated launch date.
- Profile of each pipeline product with additional information on product description, function, technology, indication(s), and application.
- Data on relevant clinical trials and product patent details, wherever applicable.
- Information on clinical trial, wherever applicable, is supplemented with information on trial phase, trial status, trial objective, trial design, target patients, unique physician identifier, primary point, secondary point, acronym, participants inclusion, participants exclusion, interventions, trial results, trial start date, trial end date, study type, trial site, trial funding, age eligibility, and gender eligibility.
Reasons to Buy
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape globally.
- Design and develop your product development, marketing and sales strategies.
- Exploit M&A opportunities by identifying market players with the most innovative pipeline.
- Develop market-entry and market expansion strategies.
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return.
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
- Develop competition strategies by identifying the status and likely launch of your competitors’ pipeline products through review of the clinical trials, stage and phase of development, etc.
- Which are the next high-value products that your competitor would add in its portfolio? – identify, understand and capitalize.
Summary
Cytori Therapeutics, Inc. (Cytori) is a medical device company, engaged in the development and commercialization of stem and regenerative cell therapies for the treatment of cardiovascular disease, reconstructive surgery and many other serious, chronic, and life threatening conditions. The company’s primary technology is the patented Celution family of products which processes patients’ adipose-derived stem and regenerative cells (ADRCs) at the point of care. It sells its products directly or through distribution partners in various European countries including Finland, Italy, the Netherlands, Norway, Portugal, Spain, Austria, Belgium, Denmark, Germany, Greece, Sweden, Switzerland, Turkey, and the UK, as well is in select Asian, the Middle Eastern, and eastern European countries. Cytori is headquartered in San Diego, California, the US.
This report is a source for data, analysis and actionable intelligence on the Cytori Therapeutics, Inc. portfolio of pipeline products. The report provides detailed analysis on each pipeline product with information on the indication, the development stage, trial phase, product milestones, pipeline territory, estimated approval date, and estimated launch date.
Each pipeline product is profiled to cover information on product description, function, technology, indication, and application. The report is also supplemented with a detailed company profile and information on clinical trials, wherever applicable.
This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.
Scope
- Detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments.
- Detailed coverage on all the pipeline products, by equipment type, by therapy area, by development stage, and by trial phase.
- Information on product milestones and pipeline territory for each product, the estimated approval date, and estimated launch date.
- Profile of each pipeline product with additional information on product description, function, technology, indication(s), and application.
- Data on relevant clinical trials and product patent details, wherever applicable.
- Information on clinical trial, wherever applicable, is supplemented with information on trial phase, trial status, trial objective, trial design, target patients, unique physician identifier, primary point, secondary point, acronym, participants inclusion, participants exclusion, interventions, trial results, trial start date, trial end date, study type, trial site, trial funding, age eligibility, and gender eligibility.
Reasons to Buy
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape globally.
- Design and develop your product development, marketing and sales strategies.
- Exploit M&A opportunities by identifying market players with the most innovative pipeline.
- Develop market-entry and market expansion strategies.
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return.
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
- Develop competition strategies by identifying the status and likely launch of your competitors’ pipeline products through review of the clinical trials, stage and phase of development, etc.
- Which are the next high-value products that your competitor would add in its portfolio? – identify, understand and capitalize.
Contents:
List of Tables
List of Figures
Cytori Therapeutics, Inc. - Business Description
Key Facts
Cytori Therapeutics, Inc. - Major Products and Services
Cytori Therapeutics, Inc. Pipeline Products by Equipment Type
Cytori Therapeutics, Inc. Pipeline Products by Development Stage
Cytori Therapeutics, Inc. Pipeline Products by Therapy Area
Cytori Therapeutics, Inc. Pipeline Products by Trial Phase
Cytori Therapeutics, Inc. Pipeline Products by Milestone Summary
Celution 700 System
Product Status
Product Description
Product Milestone
Product Patent Details
Celution 800/CRS System
Product Status
Product Description
Product Milestone
Celution 800/CRS System Clinical Trial
Product Patent Details
Celution One System
Product Status
Product Description
Product Milestone
Celution One System Clinical Trial
Product Patent Details
Pure Graft
Product Status
Product Description
Product Milestone
Cytori Therapeutics, Inc. - Key Competitors
Cytori Therapeutics, Inc. - Key Employees
Cytori Therapeutics, Inc. - Key Employee Biographies
Cytori Therapeutics, Inc. - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Recent Developments
Jun 02, 2011: Cytori Receives Cell-Enriched Fat Grafting Patent In Japan
May 17, 2011: Cytori Announces Independent Clinical Study Results In Breast Reconstruction Presented At Association of Breast Surgery Conference
May 06, 2011: Cytori Appoints Clyde W Shores As Executive Vice President, Marketing And Sales
May 05, 2011: Cytori Reports Product Revenues Of $1.4m In Q1 2011
May 04, 2011: Cytori To Install StemSource Cell Bank For Neo Derm In Hong Kong
May 03, 2011: Cytori Announces Management Changes
Mar 10, 2011: Cytori Reports Product Revenues Of $8.2m In 2010
Mar 03, 2011: Cytori Therapeutics Establishes European Sales Headquarters In Switzerland
Mar 02, 2011: Cytori Therapeutics Establishes European Sales Headquarters In Switzerland And Launches Cytori Exchange
Feb 25, 2011: Cytori Receives Japanese Patent For Celution System Technology
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer
Companies Mentioned
Osiris Therapeutics, Inc.
MG Biotherapeutics, LLC
Geron Corporation
Bioheart, Inc.
Aastrom Biosciences, Inc.
MG Biotherapeutics, LLC
Geron Corporation
Bioheart, Inc.
Aastrom Biosciences, Inc.
Ordering:
Order Online - visit http://www.researchandmarkets.com/reports/1582661
Order by Fax - using the order form below
Order By Post - print the order form below and send to
Research and Markets,
Guinness Centre,
Taylors Lane,
Dublin 8,
Ireland.
Page 1 of 2
Printed Saturday, May 25, 2013
6:01:16 PM
6:01:16 PM
Fax order form
To place a fax order simply print this form, fill in and fax the completed form to the number below. If you have any questions please email help@researchandmarkets.net
Order information
Please verify that the product information is correct and select the format you require.
Product name
Cytori Therapeutics, Inc. (XMP) - Product Pipeline Analysis
Web Address
http://www.researchandmarkets.com/reports/1412738
Office Code
OC8DIQSMMRWVYY
Report Formats
Please enter the quantity of the report format you require.
| Format | Quantity | Price | Electronic (PDF) - Single User |
|
EURO€ 576.00 |
|---|---|---|
| Electronic (PDF) - Enterprisewide |
|
EURO€ 1,729.00 |
| Electronic (PDF) - Site License |
|
EURO€ 1,153.00 |
Contact information
Please enter all the information below in block capitals.
Title:
Mr
Mrs
Dr
Miss
Ms
Prof
Mrs
Dr
Miss
Ms
Prof
First Name:
Last Name:
Email Address:
Job Title:
Organisation:
Address:
City:
Postal / Zip Code:
Country:
Phone Number:
Fax Number:
Please fax this form to:
(646) 607-1907 or (646) 964-6609 (from USA)
+353-1-481-1716 or +353-1-653-1571 (from Rest of World)
Page 2 of 2
Printed Saturday, May 25, 2013
6:01:16 PM
6:01:16 PM
Payment information
Please indicate the payment method you would like to use by selecting the appropriate box.
Pay by Credit Card:
American Express
Diners Club
Master Card
Visa
Cardholder's Name:
Cardholder's Signature:
Expiry Date:
/
Card Number:
CVV Security Code:
Issue date:
/ (Diners Club only)
Pay by Check:
Please post the check, accompanied by this form, to:
Research and Markets,
Guinness Centre,
Taylors Lane,
Dublin 8,
Ireland.
Pay by Wire Transfer:
Please transfer funds to:
Account Number:
83313083
Sort Code:
98-53-30
Swift Code:
ULSBIE2D
IBAN Number:
IE78ULSB98533083313083
Bank Address:
Ulster Bank,
27-35 Main Street
Blackrock,
Co. Dublin
Ireland.
27-35 Main Street
Blackrock,
Co. Dublin
Ireland.
If you have a Marketing Code please enter it below:
Marketing Code:
Please note that by ordering from Research and Markets you are agreeing to our Terms and Conditions at http://www.researchandmarkets.com/info/terms.asp